Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALL.
Kathryn G. Roberts(St. Jude Children's Research Hospital), Charles Mullighan(St. Jude Children's Research Hospital), Zhaohui Gu(City of Hope), Yung‐Li Yang(St. Jude Children's Research Hospital), Stephen P. Hunger(Children's Hospital of Philadelphia), Kirsten Dickerson(St. Jude Children's Research Hospital), Taosheng Chen(St. Jude Children's Research Hospital), Jack Taunton(University of British Columbia), Wenwei Lin(St. Jude Children's Research Hospital), Laura J. Janke(St. Jude Children's Research Hospital), Jacob K. Files(University of Alabama at Birmingham), Debbie Payne-Turner(St. Jude Children's Research Hospital), Mignon L. Loh(Seattle Children's Hospital)
Cited by 114
Related Papers
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
|Science|1999|11.6k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k